FDA Warns Of Severe Risks Associated With Medtronic Leadless Pacemakers
Medtronic welcomes agency’s recommendations, highlights device’s safety record
The US Food and Drug Administration has issued a warning to clinicians of the heightened risk for adverse events, including death, from potential cardiac perforation during implantation of Medtronic’s Micra Transcatheter Pacing System (TPS).
